Jedd D. Wolchok Google Scholar: h-index, Total Citations, and Citation Map
Jedd D. Wolchok's h-index is 175 (545 i10-index, 207,807+ total citations across 1,487+ publications) according to Google Scholar as of October 2026. Jedd D. Wolchok is affiliated with Memorial Sloan Kettering Cancer Center.
Jedd D. Wolchok is a researcher affiliated with Memorial Sloan Kettering Cancer Center, specializing in various fields. Their work has been cited 207,807 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Jedd D. Wolchok's Citation Metrics
Bibliometric impact based on 1,487 indexed publications.
- H-Index
- 175
- i10-Index
- 545
- Total Citations
- 207,807
- Citing Countries
- 57
As of October 2026.
Jedd D. Wolchok has an h-index of 175 and 207,807 total citations across 1487 publications, with research cited by institutions in 57 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Jedd D. Wolchok's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
201015,037
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Jedd D. Wolchok's research
Jedd D. Wolchok is a researcher at Memorial Sloan Kettering Cancer Center. Their work has been cited 207,807 times across 1,487 publications (h-index 175), according to Google Scholar.
Their most-cited work, “Improved Survival with Ipilimumab in Patients with Metastatic Melanoma” (2010), has accumulated 15,037 citations. Other influential works include “Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma” (2015) with 8,055 citations and “Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer” (2015) with 7,864 citations.
Citations of Jedd D. Wolchok's research come primarily from China, United States and Australia, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
